- Previous Close
35.45 - Open
31.67 - Bid 36.97 x --
- Ask 36.98 x --
- Day's Range
35.51 - 38.08 - 52 Week Range
25.72 - 38.08 - Volume
46,363,938 - Avg. Volume
16,957,308 - Market Cap (intraday)
59.128B - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
19.58 - EPS (TTM)
1.89 - Earnings Date --
- Forward Dividend & Yield 0.52 (1.47%)
- Ex-Dividend Date Oct 23, 2024
- 1y Target Est
43.29
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.
www.kelun.com19,798
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 002422.SZ
View MorePerformance Overview: 002422.SZ
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002422.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002422.SZ
View MoreValuation Measures
Market Cap
59.13B
Enterprise Value
56.83B
Trailing P/E
19.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.57
Price/Book (mrq)
2.62
Enterprise Value/Revenue
2.53
Enterprise Value/EBITDA
11.52
Financial Highlights
Profitability and Income Statement
Profit Margin
13.17%
Return on Assets (ttm)
7.22%
Return on Equity (ttm)
14.14%
Revenue (ttm)
22.5B
Net Income Avi to Common (ttm)
2.96B
Diluted EPS (ttm)
1.89
Balance Sheet and Cash Flow
Total Cash (mrq)
7.08B
Total Debt/Equity (mrq)
21.79%
Levered Free Cash Flow (ttm)
1.33B